neuroaid

Botanicalexperimental

NeuroAiD is a herbal supplement proposed to support functional recovery after strokes. There were two formulations of NeuroAiD: MLC601 (NeuroAiDTM) was first developed. Since 2018 MLC601 formulation is no longer on the market, and has been replaced by MLC901 (NeuroAiDTMII), a simplified formulation containing only 9 botanical ingredients. It can be administered orally or through a feeding tube. — Wikipedia

Clinical trial activity

5 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
4
Phase 3
1
Phase 4
1

Earliest trial started May 1, 2007 (NCT00554723)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • mlc 601
  • mlc901
  • mlc901
  • mlc 901
  • neuroaid
  • neuroaid

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03038035Phase 2Dec 1, 2016National University of Singapore
NCT02537899Phase 4Jun 1, 2015Moleac Pte Ltd., National University of Malaysia
NCT01847924Phase 2Mar 1, 2013National University of Singapore
NCT00721825Phase 2Jan 1, 2008Moleac Pte Ltd., Nanyang Technological University
NCT00554723Phase 3May 1, 2007CHIMES Society, Government of Singapore, National University of Singapore, University of Paris
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National University of SingaporeAcademic/Hospital3222007
Moleac Pte Ltd.For profit2222008
CHIMES SocietyAcademic/Hospital1112007
Government of SingaporeGovernment1012007
Nanyang Technological UniversityAcademic/Hospital1012008
National University of MalaysiaAcademic/Hospital1012015
University of ParisAcademic/Hospital1012007
7 organizations
Page 1 / 1